SkinHealth Systems (SKIN) Convertible Debt (2021 - 2026)

SkinHealth Systems (SKIN) has 6 years of Convertible Debt data on file, last reported at $344.2 million in Q1 2026.

• On a quarterly basis, Convertible Debt fell 37.75% year-over-year to $344.2 million in Q1 2026; TTM through Mar 2026 was $344.2 million, a 37.75% decrease from a year earlier, with the FY2025 full-year figure at $240.4 million, down 56.46% from the prior year.
• Convertible Debt for Q1 2026 stood at $344.2 million, up from $240.4 million in the prior quarter.
• Over the last five years, Convertible Debt for SKIN reached as high as $738.4 million in Q4 2023 and fell as low as $240.4 million in Q4 2025.
• Historically, Convertible Debt has averaged $591.8 million across 5 years, with a median of $665.5 million in 2024.
• Across the five-year window, Convertible Debt advanced 0.58% in 2022 and tumbled 56.46% in 2025, its largest moves.
• Year by year, Convertible Debt stood at $734.1 million in 2022, then increased by 0.58% to $738.4 million in 2023, then declined by 25.21% to $552.2 million in 2024, then tumbled by 56.46% to $240.4 million in 2025, then soared by 43.17% to $344.2 million in 2026.
• Per Business Quant data, the three most recent Convertible Debt figures were $344.2 million in Q1 2026, $240.4 million in Q4 2025, and $363.4 million in Q3 2025.